Similarly, RNA sequencing of postmortem patient tissue indicates that MATR3 expression increases in mild and moderate disease stages before dropping in late stages (90), supporting dysregulation of MATR3 expression as well as localization in ALS. This evidence concerns the gene MATR3 and amyotrophic lateral sclerosis.